SENTHIL DAMODARAN to BRCA1 Protein
This is a "connection" page, showing publications SENTHIL DAMODARAN has written about BRCA1 Protein.
Connection Strength
0.035
-
Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant. J Clin Oncol. 2020 02 10; 38(5):388-394.
Score: 0.035
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.